With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.33454-82-9,Lithium trifluoromethanesulfonate,as a common compound, the synthetic route is as follows.
1.43 parts by mass of 4-fluoroanisole sulfide, 1.95 parts by mass of silver tetrafluoroborate, and 1-chloromethylnaphthalene 1.77 parts by massAnd 10.0 parts by mass of acetone were uniformly mixed and reacted at 25 C for 24 hours. After removal of silver chloride,The reaction solution was transferred to a rotary evaporator, and the solvent was distilled off, and 10.0 parts by mass of acetone, 10.0 parts of hexane,By mass. 3.33 parts by mass of the obtained precipitate, 1.56 parts by mass of lithium trifluoromethanesulfonate,And 10 parts by mass of acetone were mixed and reacted at 25C for 24 hours. To the reaction solution, 10.0 g of distilled water was addedLt; / RTI & gt; The solvent was removed from the organic layer under reduced pressure, whereby 3.24 parts by mass of the compound 9 was obtained.The mass ratio of the compound B to the total mass of the compound B and the compound A was 0.965. Compared to 4-The yield of fluoroanisole sulfide was 75%. The mass of compound B was 3.13 g and the mass of compound A was 0.11 g.
As the paragraph descriping shows that 33454-82-9 is playing an increasingly important role.
Reference£º
Patent; Asahi Kasei Electronic Materials Co., Ltd.; Zhi, Cunzhong; Shang, Cunzhimi; Da, Guzhang; Dao, Tianren; (89 pag.)CN105579436; (2016); A;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI